跳至主要内容
临床试验/NL-OMON35999
NL-OMON35999已完成不适用

Assessment of the performance of the new generation Pillcam colon capsule (PCCE 2) in Crohn's disease: an exploratory study. - Pillcam study

Academisch Medisch Centrum0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Active Crohn's disease with CDAI > 150
  • * Elevated serum CRP (> 5 mg/l) and fecal calprotectin (> 200 ng/mg)
  • * Prior documentation of colonic involvement by Crohn's disease in at least one segment of the colon and more severe than only aphthous lesions
  • * Colonoscopy clinically indicated

排除标准

  • * Any contraindication for colonoscopy or colon capsule examination including swallowing disorders, severe congestive heart failure, renal insufficiency
  • * More than 1 resectional surgery for CD
  • * Subtotal or total colectomy
  • * Severely active fistulising disease
  • * Jejunal Crohn's disease
  • * HIgh suspicion of small bowel strictures
  • * Short bowel syndrome or stoma

研究者

相似试验